Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Benchmark Maintains Buy on Builders FirstSource, Raises Price Target to $115

Benchmark Maintains Buy on Builders FirstSource, Raises Price Target to $115

Benchmark analyst Reuben Garner maintains Builders FirstSource (NYSE:BLDR) with a Buy and raises the price target from $95 to $115.

byBenzinga Newsdesk

March 1, 2023

1 minute read

Benchmark analyst Reuben Garner maintains Builders FirstSource (NYSE:BLDR) with a Buy and raises the price target from $95 to $115.

HeartBeam Appoints Robert Eno As President

By Benzinga Newsdesk

January 24, 9:33 AM

Senior Medical Technology Executive to Enhance Company's Strategic and Operations Capabilities HeartBeam, Inc. (NASDAQ:BEAT), a cardiac technology company that has developed the first and only 3D-vector

BEAT

Analyst Ratings

Expert Ratings for EPAM Sys

By Benzinga Insights

Yesterday, 3:00 PM

Within the last quarter, EPAM Sys (NYSE:EPAM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

EPAM

These Analysts Cut Their Forecasts On Salesforce After Q1 Results

By Avi Kapoor

May 30, 8:37 AM

Salesforce Inc (NYSE:CRM) reported upbeat earnings for the first quarter, while sales missed estimates. Salesforce reported first-quarter revenue…

CRM

Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge

By Lisa Levin

January 6, 1:01 PM

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.

AEHR

Benchmark Maintains Buy on Builders FirstSource, Raises Price Target to $115

Related Posts

HeartBeam Appoints Robert Eno As President

Expert Ratings for EPAM Sys

These Analysts Cut Their Forecasts On Salesforce After Q1 Results

Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge